|
Volumn 30, Issue 4, 1998, Pages 1185-1187
|
Therapeutic drug monitoring of mycophenolic acid: Comparison of HPLC and immunoassay reveals new MPA metabolites
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CYCLOSPORIN;
DRUG METABOLITE;
MYCOPHENOLIC ACID;
TACROLIMUS;
ADULT;
AREA UNDER THE CURVE;
CHILD;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED STUDY;
DRUG BLOOD LEVEL;
DRUG MONITORING;
ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE;
GRAFT REJECTION;
HEART TRANSPLANTATION;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY TRANSPLANTATION;
LIVER TRANSPLANTATION;
MAJOR CLINICAL STUDY;
PRIORITY JOURNAL;
REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
ADULT;
CHILD;
CHROMATOGRAPHY, HIGH PRESSURE LIQUID;
CYCLOSPORINE;
DRUG MONITORING;
DRUG THERAPY, COMBINATION;
ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE;
HEART TRANSPLANTATION;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
LIVER TRANSPLANTATION;
METABOLIC CLEARANCE RATE;
MYCOPHENOLIC ACID;
|
EID: 0344890150
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(98)00201-2 Document Type: Conference Paper |
Times cited : (111)
|
References (8)
|